TrialRespiratory research2017

Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.

Claus F Vogelmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.